Thrombotic Thrombocytopenic Purpura: aetiology, pathophysiology and treatment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Moschcowitz, 1924, Hyaline thrombosis of the terminal arterioles and capilliaries: a hitherto undescribed disease, Proc NY Pathol Soc, 24, 21
Amorisi, 1966, Thrombotic thrombocytopenic purpura :report of 16 cases and review of the literature, Medicine, 45, 139, 10.1097/00005792-196603000-00003
Ridolfi, 1981, Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature, Medicine, 60, 413, 10.1097/00005792-198111000-00003
Rock, 1998, Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group, Br J Haem, 103, 1031, 10.1046/j.1365-2141.1998.01080.x
Fava, 1995, Thrombotic thrombocytopenic purpura – like syndrome in the absence of schistocytes, Br J Haem, 89, 643, 10.1111/j.1365-2141.1995.tb08379.x
Jandl, 1997
Cohen, 1998, Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura, Clin Apheresis, 13, 16, 10.1002/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C
Cuttner, 1980, Thrombotic thrombocytopenic purpura: a ten year experience, Blood, 56, 302, 10.1182/blood.V56.2.302.302
Silverstein, 1968, Thrombotic thrombocytopenic purpura: the initial neurological manifestation, Arch Neurol, 18, 358, 10.1001/archneur.1968.00470340044003
Sarode, 1997, Thrombotic thrombocytopenic purpura: early and late responders, Am J Haem, 54, 102, 10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0
Rabkin, 2000, Chronic relapsing thrombocytopenic purpura with severe neurological manifestations and full recovery, Int J Haematol, 71, 184
George, 2000, How I treat patients with thrombotic thrombocytopenic purpura – hemolytic uremic syndrome, Blood, 96, 1223, 10.1182/blood.V96.4.1223
Olsen, 1973, Thrombotic thrombocytopenic purpura as a cause of pancreatitis: report of a case and review of the literature, Dig Dis, 18, 238, 10.1007/BF01071978
Elias, 1985, Thrombotic thrombocytopenic purpura presenting as an acute abdomen, Br J Surg, 72, 286, 10.1002/bjs.1800720413
Winwood, 1992, Thrombotic thrombocytopenic purpura mimicking acute small bowel Crohn’s disease, Gut, 33, 857, 10.1136/gut.33.6.857
Ross, 1987, Sudden death due to thrombotic thrombocytopenic purpura, Am J Forensic Med Pathol, 8, 158, 10.1097/00000433-198708020-00015
Bell, 1990, Thrombotic thrombocytopenic purpura causing sudden unexpected death – a series of 8 patients, Am J Forensic Sci, 35, 601, 10.1520/JFS12866J
Ridolfi, 1979, The heart and cardiac conduction system in thrombotic thrombocytopenic purpura: a clinicopathologic study of 17 autopsied patients, Ann Intern Med, 91, 357, 10.7326/0003-4819-91-3-357
Torok, 1995, Increasing mortality from thrombotic thrombocytopenic purpura in the United States – nalysis of national mortality data, 1968–1991, Am J Haem, 50, 84, 10.1002/ajh.2830500203
Levine SP. Thrombotic thrombocytopenic purpura and other forms of non-immunologic platelet destruction in: Wintrobe’s Clinical Haematology (Tenth Edition): Williams and Wilkins 1999.
May, 1976, Thrombotic thrombocytopenic purpura associated with pregnancy, Am J Obstet Gynaecol, 126, 452, 10.1016/0002-9378(76)90638-4
Schriber, 1997, Transplantation-associated thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome, Sem in Haematology, 34, 126
Bennett, 1998, Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases, Ann Intern Med, 128, 541, 10.7326/0003-4819-128-7-199804010-00004
Leaf, 1988, Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection, Ann Intern Med, 109, 194, 10.7326/0003-4819-109-3-194
Raife, 1998, Von Willebrand Factor proteolysis and doxycycline in thrombotic thrombocytopenic purpura, Lancet, 352, 324, 10.1016/S0140-6736(05)60302-9
Gordon, 1999, Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura / haemolytic uraemic syndrome in the cancer patient, Seminars in Thrombosis and Haemostasis, 25, 217, 10.1055/s-2007-994923
Allford, 2003, Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias, Br J Haem, 120, 556, 10.1046/j.1365-2141.2003.04049.x
Byrness, 1986, Thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome; evolving concepts of pathogenesis and therapy, Clin Haematol, 15, 413, 10.1016/S0308-2261(18)30024-9
Asada, 1985, Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura with special reference to factor VIII related antigen, Thromb Res, 38, 469, 10.1016/0049-3848(85)90180-X
Kwaan, 1987, Clinicopathologic features of thrombotic thrombocytopenic purpura, Sem in Haem, 24, 71
Laurence, 1996, Plasma from patients with idiopathic and human immunodeficiency virus associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells, Blood, 87, 3254, 10.1182/blood.V87.8.3245.bloodjournal8783245
Dang, 1999, Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura, Blood, 93, 1264, 10.1182/blood.V93.4.1264
Tandon, 1994, Anti CD 36 antibodies in thrombotic thrombocytopenic purpura, Br J Haem, 88, 816, 10.1111/j.1365-2141.1994.tb05122.x
Sverlick, 1992, Human dermal microvascular endothelial but human umbilical vein endothelial cells express CD 36 in vivo and in vitro, Journal of Immunology, 148, 78, 10.4049/jimmunol.148.1.78
Lian, 1979, Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma, Blood, 53, 333, 10.1182/blood.V53.2.333.333
Lian, 1991, Platelet agglutinating protein p37 causes platelet agglutination through its binding to membrane glycoprotein IV, Thromb Haemostas, 65, 102, 10.1055/s-0038-1647462
Murphy, 1987, Calcium dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura, Blood, 70, 1683, 10.1182/blood.V70.5.1683.1683
Moore, 1990, Calpain proteolysis of von Willebrand Factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura, Br J Haem, 74, 457, 10.1111/j.1365-2141.1990.tb06335.x
Kelton, 1992, Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles, Blood, 80, 2246, 10.1182/blood.V80.9.2246.2246
Moake, 1982, Unusually large plasma factor VIII: von Willebrand Factor multimers in chronic relapsing thrombotic thrombocytopenic purpura, N Eng J Med, 307, 1432, 10.1056/NEJM198212023072306
Moake, 1986, Involvement of large plasma von Willebrand Factor (VWF) multimers and unusually large VWF forms derived from endothelial cells in shear stress-induced platelet aggregation, J Clin Invest, 78, 1456, 10.1172/JCI112736
Moake, 1985, Effects of fresh frozen plasma and its cryosupernatant fraction on von Willebrand Factor mulimeric forms in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 65, 1232, 10.1182/blood.V65.5.1232.1232
Furlan, 1996, Partial purification and characterization of a protease from human plasma cleaving von Willebrand Factor to fragments predicted by in vitro proteolysis, Blood, 87, 4223, 10.1182/blood.V87.10.4223.bloodjournal87104223
Furlan, 1997, Deficient activity of von Willebrand Factor – cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097
Furlan, 1998, Von Willebrand Factor-cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome, N Engl J Med, 339, 1578, 10.1056/NEJM199811263392202
Sarkodee-Adoo, 1999, Von Willebrand Factor-cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome, N Engl J Med, 340, 1368, 10.1056/NEJM199904293401714
Tsai, 1998, Antibodies to von Willebrand Factor – cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203
Dent, 1990, Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type II Von Willebrand Factor, Proc Natl Acad Sci USA, 87, 6306, 10.1073/pnas.87.16.6306
Tsai, 1994, Shear stress enhances the proteolysis of von Willebrand Factor in normal plasma, Blood, 83, 2171, 10.1182/blood.V83.8.2171.2171
Tsai, 1997, Proteolytic cleavage of recombinant type 2A von Willebrand Factor mutants R843W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1, Blood, 89, 1954, 10.1182/blood.V89.6.1954
Fujikawa, 2001, Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family, Blood, 98, 1662, 10.1182/blood.V98.6.1662
Gerritsen, 2001, Partial amino acid sequence of purified von Willebrand factor-cleaving protease, Blood, 98, 1654, 10.1182/blood.V98.6.1654
Levy, 2001, Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, 413, 488, 10.1038/35097008
Hurskainen, 1999, ADAM-TS5, ADAM-TS6 and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family, Journal of Biological Chemistry, 274, 25555, 10.1074/jbc.274.36.25555
Mannucci, 1999, Thrombotic thrombocytopenic purpura: a simpler diagnosis at last, Thromb Haemostas, 82, 1380, 10.1055/s-0037-1614778
Raife, 2000, Von Willebrand Factor and thrombotic thrombocytopenic purpura, Current Opinion in Haematology, 7, 278, 10.1097/00062752-200009000-00004
Byrness, 1977, Treatment of thrombotic thrombocytopenic purpura with plasma, N Engl J Med, 297, 1386, 10.1056/NEJM197712222972507
Lankford, 2000, Thrombotic thrombocytopenic purpura: new insights in disease pathogenesis and therapy, Transfusion Medicine Reviews, 14, 244, 10.1053/tm.2000.7394
Rock, 1991, Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med, 325, 393, 10.1056/NEJM199108083250604
Rock, 2000, Management of thrombotic thrombocytopenic purpura, Br J Haem, 109, 496, 10.1046/j.1365-2141.2000.01941.x
Moake, 1998, Moschcowitz, multimers and metalloprotease, N Engl J Med, 339, 1629, 10.1056/NEJM199811263392210
Byrnes, 1990, Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura, Am J Haem, 34, 169, 10.1002/ajh.2830340303
Rock, 1996, Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura, Br J Haem, 94, 383, 10.1046/j.1365-2141.1996.d01-1800.x
Owens, 1995, Influence of type of exchange fliud on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura, Journal of Clinical Apheresis, 10, 178, 10.1002/jca.2920100404
Ziegler, 2001, North American TTP group. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP), J Clin Apheresis, 16, 19, 10.1002/jca.1003
Moake, 1994, Solvent / detergent – treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura, Blood, 84, 490, 10.1182/blood.V84.2.490.490
O’Shaughnessy, 2004, British Committee for Standards in Haematology, Blood Transfusion Task Force (J Duguid, Chairman). Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant, Br J Haem, 126, 11, 10.1111/j.1365-2141.2004.04972.x
Bandarenko, 1998, United States Thrombotic Thrombocytopenic Purpura Study Group (US TTP ASG) : multicentre survey and retrospective analysis of current efficacy of therapeutic plasma exchange, Journal of Clinical Apheresis, 13, 133, 10.1002/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z
Bell, 1991, Improved survival in thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome. Clinical experience in 108 patients, N Engl J Med, 325, 398, 10.1056/NEJM199108083250605
Hoffman, 1993, Platelet activation in patients with thrombotic thrombocytopenic purpura, Am J Haem, 42, 182, 10.1002/ajh.2830420208
Chow, 1998, Increased von Willebrand Factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura, Am J Haem, 57, 293, 10.1002/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P
Moake, 1998, Shear induced platelet aggregation can be mediated by von Willebrand Factor released from platelets as well as by exogenous large or unusually large von Willebrand Factor multimers, requires adenosine triphosphate, and is resistant to aspirin, Blood, 71, 1366, 10.1182/blood.V71.5.1366.1366
Harkness, 1981, Hazard of platelet transfusion in thrombotic thrombocytopenic purpura, JAMA, 246, 1931, 10.1001/jama.246.17.1931
Gordon, 1987, Deleterious effects of platelet transfusion and recovery thrombocytosis in patients with thrombotic microangiopathy, Seminars in Haematology, 24, 194
Brittingham, 1957, Attempted passive transfer of thrombotic thrombocytopenic purpura, Blood, 12, 480, 10.1182/blood.V12.5.480.480
Porta, 1993, Thrombotic thrombocytopenic purpura resistant to plasma exchange: salvage treatment with high dose IgG or vincristine. Italian Cooperative Group for TTP, Int J Artif Organs, 201, 10.1177/039139889301605s45
Gaddis, 1997, Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption, Am J Haem, 55, 55, 10.1002/(SICI)1096-8652(199706)55:2<55::AID-AJH1>3.0.CO;2-1
Rowe, 1985, Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand Factor multimers, Am J Haem, 20, 161, 10.1002/ajh.2830200209
Schneider, 1985, The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpura, Ann Surg, 202, 318, 10.1097/00000658-198509000-00007
Hoffkes, 1995, Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange, Semin Thromb Haemostas, 21, 161, 10.1055/s-2007-1000391
Burns, 1982, Pathological effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells, Blood, 60, 1030, 10.1182/blood.V60.4.1030.1030
Welborn, 1990, Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis, Am J Haem, 35, 18, 10.1002/ajh.2830350105
Bobbio-Pallavicini, 1994, Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma exchange. The Italian Cooperative group for TTP, Eur J Haem, 52, 222, 10.1111/j.1600-0609.1994.tb00649.x
Mazzel, 1998, Treatment of thrombotic thrombocytopenic purpura: a role for early vincristine administration, J Clin Apheresis, 13, 20, 10.1002/(SICI)1098-1101(1998)13:1<20::AID-JCA4>3.0.CO;2-B
Pasquale, 1998, Chronic relapsing thrombotic thrombocytopenic purpura: role of therapy with cyclosporine, Am J Haem, 57, 57, 10.1002/(SICI)1096-8652(199801)57:1<57::AID-AJH10>3.0.CO;2-6
Hand, 1998, Successful use of cyclosporin A in the treatment of refractory thrombotic thrombocytopenic purpura, Br J Haem, 100, 597, 10.1046/j.1365-2141.1998.00602.x
Pescador, 1996, An integrated view of the activities of defibrotide, Semin Thromb Haemost, 22, 71
Bianchi, 1993, Defibrotide, a single stranded polydeoxyribonucleotide acting as an adenosine receptor agonist, Eur J Pharmacol, 238, 327, 10.1016/0014-2999(93)90864-E
Pasini, 1996, Modulation of venous endothelial activity and transcellular calcium transport by defibrotide: the adenosine hypothesis, Semin Thromb Haemost, 22, 15
Ulutin, 1996, Effect of defibrotide on plateket function, Semin Thromb Haemost, 22, 21
Remuzzi, 1978, Haemolytic uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity, Lancet, 2, 871, 10.1016/S0140-6736(78)91573-8
Pogliani, 2000, Defibrotide in recurrent thrombotic thrombocytopenic purpura, Clin Appl Thromb Haemost, 6, 69, 10.1177/107602960000600203
Corti, 2002, Defibrotide as a growing treatment for thrombotic thrombocytopenic purpura in patients undergoing BMT, Bone Marrow Transplantation, 29, 542, 10.1038/sj.bmt.1703414
Perotti, 1994, Thrombotic thrombocytopenic purpura after defibrotide therapy, Haematologica, 79, 569
Shumak, 1995, Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group, Ann Intern Med, 122, 569, 10.7326/0003-4819-122-8-199504150-00002
Winslow, 1995, Thrombotic thrombocytopenic purpura: indications for and results of splenectomy, Am J Surgery, 170, 558, 10.1016/S0002-9610(99)80015-4
Crowther, 1996, Splenectomy done during haematological remission to prevent relapse in patients with thrombotic thrombocytopenic purpura, Ann Intern Med, 125, 294, 10.7326/0003-4819-125-4-199608150-00006
Bobbio-Pallavicini, 1997, Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP, Haematologica, 82, 429
Veyradier, 2001, Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, 98, 1765, 10.1182/blood.V98.6.1765
Patton, 1994, Serum lactate dehydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura, Am J Haem, 47, 94, 10.1002/ajh.2830470206